| 摘要 |
The present invention relates to a method for inhibiting lung cancer of smokers and non-smokers by blocking the signaling of growth factors through the use of a hypertension medicine and, more specifically, to a pharmaceutical composition for preventing or treating lung cancer, containing a hypertension medicine as an active ingredient. The present invention suggests a novel use of a hypertension medicine, currently in clinical use, for preventing lung cancer, and can be directly applied to an early-stage lung cancer or lung cancer high-risk group. Especially, the present invention can exclude the worry of safety, involved in the clinical application of new drugs, thereby increasing the possibility of the clinical application, and significantly reduce enormous costs and time consumed from the development to the clinical application of new drugs. |
